Treatment Of Cancer Via Targeting of IL-13 Receptor-alpha2
Technology
E-161-2007
Patent ID
E-161-2007-0-US-03
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
US20110268749A1
Application Number
12/671,652
IC
NIAID
Date Filed
Date Issued
Patent PDF